These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38160936)

  • 1. Risk Prediction Scores for Type 2 Diabetes Microvascular and Cardiovascular Complications Derived and Validated With Real-world Data From 2 Provinces: The DIabeteS COmplications (DISCO) Risk Scores.
    Shah BR; Austin PC; Ivers NM; Katz A; Singer A; Sirski M; Thiruchelvam D; Tu K
    Can J Diabetes; 2024 Apr; 48(3):188-194.e5. PubMed ID: 38160936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Yudkin JS
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):788-798. PubMed ID: 28803840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
    Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
    Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
    Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
    Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.
    Tanaka S; Tanaka S; Iimuro S; Yamashita H; Katayama S; Akanuma Y; Yamada N; Araki A; Ito H; Sone H; Ohashi Y; ;
    Diabetes Care; 2013 May; 36(5):1193-9. PubMed ID: 23404305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Salles GC; Leite NC; Salles GF
    Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease.
    Ng R; Sutradhar R; Kornas K; Wodchis WP; Sarkar J; Fransoo R; Rosella LC
    JAMA Netw Open; 2020 Jun; 3(6):e204669. PubMed ID: 32496565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early specialist care for diabetes: who benefits most? A propensity score-matched cohort study.
    Booth GL; Shah BR; Austin PC; Hux JE; Luo J; Lok CE
    Diabet Med; 2016 Jan; 33(1):111-8. PubMed ID: 25981183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
    Oellgaard J; Gæde P; Persson F; Rossing P; Parving HH; Pedersen O
    J Diabetes Complications; 2018 Dec; 32(12):1133-1140. PubMed ID: 30282584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the WATCH-DM and TRS-HF
    Segar MW; Patel KV; Hellkamp AS; Vaduganathan M; Lokhnygina Y; Green JB; Wan SH; Kolkailah AA; Holman RR; Peterson ED; Kannan V; Willett DL; McGuire DK; Pandey A
    J Am Heart Assoc; 2022 Jun; 11(11):e024094. PubMed ID: 35656988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
    Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
    PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Prediction Scores for Mortality, Cerebrovascular, and Heart Disease Among Chinese People With Type 2 Diabetes.
    Quan J; Pang D; Li TK; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Lau ZY; Tan KB; Leung GM
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5823-5830. PubMed ID: 31287503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.